Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 5.75
+0.11 (1.95%)
Sep 30, 2026, 3:04 PM CST
Daan Gene Market Cap
Daan Gene has a market cap or net worth of 8.07 billion as of October 2, 2026. Its market cap has decreased by -8.59% in one year.
Market Cap
8.07B
Enterprise Value
6.96B
Revenue
746.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.75
ChartMarket Cap Chart
Since August 9, 2004, Daan Gene's market cap has increased from 1.30B to 8.07B, an increase of 519.97%. That is a compound annual growth rate of 8.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 8.07B | -3.52% |
| Dec 31, 2025 | 8.36B | 4.93% |
| Dec 31, 2024 | 7.97B | -41.32% |
| Dec 29, 2023 | 13.59B | -37.79% |
| Dec 30, 2022 | 21.84B | -22.43% |
| Dec 31, 2021 | 28.15B | -6.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Chengdu Easton Biopharmaceuticals | 8.88B |
| Vcanbio Cell & Gene Engineering Corp., | 8.85B |
| Bio-Thera Solutions | 8.71B |
| Liaoning Chengda Biotechnology | 8.64B |
| Beijing Hotgen Biotech | 8.33B |
| Aurisco Pharmaceutical | 8.10B |
| Novogene | 8.01B |